ATHA - Athira Pharma Operating income before deduction of amortization
Athira Pharma, Inc. (ATHA) is stabilizing its image following a change in top management, as confirmed by the consolidated EBITDA metric at 0.00. This chart demonstrates the actual daily cash flow from core operations. Physician confidence is based on unique neuron regeneration methods, while the development strategy relies on the activation of the HGF/MET system to combat Alzheimer's disease.
Summary analytical data breakdowns for Athira Pharma (ATHA)
- stock quotes and analyst forecast:
- market capitalization statistics:
- balance sheet equity data:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Athira Pharma, Inc.|ATHA - Long-Term Debt to Equity|Current Liabilities to Equity Athira Pharma Inc|ATHA - Company Aggregate Debts|Debt to Net Assets Ratio Athira Pharma|ATHA - Company Long-Term Debts|Company Short-Term Debts Athira Pharma|Intermediate Coverage Ratio athira.com
- earnings and market ratios statistics:
ATHA - Company Net Income|Future Profit Athira Pharma, Inc.|ATHA - P/E Multiple|Forward P/E Multiple athira.com|ATHA - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Athira Pharma|ATHA - Operating profit EBITDA|Net earnings per share for the last four quarters Athira Pharma|ATHA - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months athira.com|ATHA - Earnings growth in current year|Expected earnings per share growth for next year Athira Pharma, Inc.
Summary company analytics:Athira Pharma Corp
This metric is calculated as the sum of operating income excluding depreciation, taxes, and interest, reflecting the business's actual ability to generate cash flow. Analyzing the EBITDA chart allows for the filtering of speculative noise and an assessment of how geopolitical barriers in reagent logistics and restrictions on global dementia research actually reduce the liquidity of Athira Pharma, Inc. (ATHA) during corporate events.
Who Athira Pharma, Inc. competes with
Income before deduction of interest, taxes and amortization BIIB|Neurocrine Biosciences - Operating profit EBITDA|Operating income before deduction of amortization regencellbioscience.com RGC|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|ACADIA Pharma - Income before deduction of interest, taxes and amortization|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|Operating profit EBITDA Viking Therapeutics Corp|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|CPRX (catalystpharma.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|HRMY (Harmony Biosciences Inc) - Profit before deduction of interest, taxes, depreciation and amortization|Biohaven Pharmaceutical - Operating profit EBITDA|Income before deduction of interest, taxes and amortization AMLX (Amylyx Corp)|TRVI: Operating profit EBITDA|praxismedicines.com (PRAX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Anavex Life Sciences Corp.|CBLL: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|Operating profit before deduction of amortization alector.com ALEC|Operating profit EBITDA ANNX (Annexon, Inc.)|Operating profit EBITDA Omeros Corp OMER|NGNE: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization ACIU (AC Immune S.A.)|VYGR: Operating profit EBITDA|NMRA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Scilex Holding Company|Operating profit before amortization TVGN (tevogen.com)|Operating profit EBITDA ACOG|Operating profit before deduction of amortization Cognition Therapeutics Inc. CGTX|Inhibikase - Operating profit before deduction of amortization|Operating income before deduction of amortization Cassava Pharma (SAVA)|Assertio Therapeutics - Operating profit EBITDA|COYA - Operating profit EBITDA|VTGN (vistagen.com) - Operating profit before deduction of amortization|OVID: Company profit before taxes, interest and amortization|ABOS (Acumen Pharma) - Operating profit EBITDA|CRVO: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ATHE|Operating profit EBITDA clene.com (CLNN)|Profit before payment of interest, taxes and amortization PepGen PEPG|JUNS: Operating profit before amortization|Relmada - Operating profit EBITDA|Profit before interest, taxes and amortization Annovis Bio Corporation|GRCE (gracetx.com) - Operating profit before deduction of amortization|fireflyneuro.com (AIFF) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization ANEW Medical|NRSN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Reviva Pharmaceuticals Holdings (RVPH)|MTVA - Profit before interest, taxes and amortization|Operating profit EBITDA NRXS (NeurAxis, Inc.)|Operating profit EBITDA Helius Medical Technologies, Inc. HSDT|PASG: Operating profit before deduction of amortization|Neuphoria Therapeutics Inc. - Company profit before taxes, interest and amortization|NERV: Operating profit EBITDA|Addex - Income before deduction of interest, taxes and amortization|ALZN (Alzamend Neuro Inc.) - Operating profit EBITDA|Cyclerion (CYCN) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA CRGT (Cortigent)|Operating profit EBITDA Avenue Therapeutics Inc ATXI|BCLI: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization CARA (caratherapeutics.com)|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ELYM (Eliem Therapeutics Inc.)|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|LBPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MRNS|Operating profit EBITDA nkgenbiotech.com (NKGN)|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|Income before deduction of interest, taxes and amortization SAGE|SNPX - Profit before payment of interest, taxes and amortization|Trevena Inc (TRVN) - Operating profit before deduction of amortization|VIGL: Operating profit EBITDA|anewmeds.com (WENA) - Operating profit EBITDA|Operating profit before deduction of amortization CERE
